Citizens, Inc. (CIA) operates as a diversified life insurer with customers across the U.S., Latin America, and Asia. Its International Insurance segment leads in U.S. dollar-denominated whole life and endowment policies, while the Domestic Insurance segment focuses on final expense and living benefits products. The company has been expanding its domestic distribution, and this quarter provides insight into whether that expansion is supporting more stable earnings. For life insurers, reserve adjustments tied to policy maturities often influence reported results, so I was particularly interested in how premium momentum and lower matured endowment payments would balance against ongoing reserve and expense pressures.
For the third quarter ended September 30, 2026, total revenues reached $65.0 million, compared with $62.8 million a year earlier and slightly above the consensus estimate of roughly $64.7 million. Adjusted total revenues, excluding investment-related gains and losses, came in at $63.6 million versus $64.1 million in the prior-year period. The company recorded a net loss of $0.4 million, or $0.01 per fully diluted Class A share, versus net income of $2.4 million, or $0.04 per share, in the third quarter of 2025. Adjusted net income was $1,000, or $0.00 per share, compared with $0.07 per share a year ago.
The earnings shortfall stemmed mainly from reserve movements rather than any softening in premiums. Direct insurance premiums increased 7% to $50.0 million, and total direct insurance in force grew to $5.6 billion from $5.38 billion. However, a $16.3 million rise in future policy benefit reserves—linked to the expanding domestic in-force block and reduced releases from matured endowments—more than offset a $13.2 million drop in claims and surrenders. Net investment income declined modestly to $18.1 million from $19.1 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investor response reflected the contrast between healthy premium growth and the reserve-driven earnings miss. The $0.01 per share net loss fell short of expectations for a modest profit, even though revenues edged above consensus. Because reserve changes are non-cash items tied to policy maturity schedules, many market participants focused on the durability of top-line growth rather than the headline miss. Sentiment also noted the divergence between the International Insurance segment, which moved to a $3.5 million pre-tax profit, and the Domestic Insurance segment, which posted a $0.9 million pre-tax loss. Book value per share slipped to $4.37 from $4.49 a year earlier.
Looking ahead, the focus will be on whether Citizens can translate its premium momentum into steadier reported profitability. Management expects lower levels of matured endowment payments over the next few years, which should help ease some of the reserve volatility seen recently. The company has also indicated that it anticipates positive net cash from operating activities for the rest of 2026 as those payments decline.
Key areas to watch include the path of future policy benefit reserves as the domestic in-force block expands, the continuation of direct first-year premium growth (now in its sixteenth straight quarter), and the productivity of the domestic agent network. Investment income trends, any actuarial assumption changes, and margin improvement—particularly a return to profitability in the Domestic Insurance segment—will also be important signals.
In my own analysis of names like CIA, I often turn to Tickeron’s AI Screener to quickly compare fundamentals, technical patterns, and performance metrics across the insurance sector. It helps surface comparable ideas without manual screening and supports a more systematic approach when evaluating growth versus profitability trade-offs. This kind of tool has become a regular part of how I cross-check sector trends and identify related opportunities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for CIA crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CIA as a result. In 78 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
CIA moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIA advanced for three days, in 205 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CIA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CIA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.889) is normal, around the industry mean (1.352). P/E Ratio (17.957) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (1.090) is also within normal values, averaging (0.463). CIA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.047). P/S Ratio (0.718) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. CIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an insurance holding company
Industry LifeHealthInsurance